Key facts
- Notable investors include Founders, Inc.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Matrix Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Matrix Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Matrix Biotech
Developer of a home testing platform designed for rapid blood testing and alcohol detection. The company's platform offers at-home biomarker testing for testing them locally with a quantitative blood alcohol test, enabling clients to redefine the biomarker testing space.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2025
- Employees
- 4
- Website
- trymatrix.bio/
- Ownership
- Privately Held (backing)
Matrix Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Matrix Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Matrix Biotech in its N-PORT filings yet. We sweep new filings monthly.